Oak Harvest Investment Services Invests $3.19 Million in Qiagen N.V. $QGEN

Key Points

• Oak Harvest Investment Services invested $3.19 million in Qiagen N.V. by acquiring 79,413 shares, reflecting growing interest from institutional investors in the company.
• Analysts have mixed ratings for Qiagen, with Bank of America increasing its target price to $53, while the consensus rating remains a "Hold" with a target price of $49.69.
• Qiagen announced a quarterly earnings of $0.60 per share, meeting expectations, with revenue of $533.54 million, representing a 7.7% year-over-year increase.

Oak Harvest Investment Services acquired a new position in Qiagen N.V. (NYSE:QGEN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 79,413 shares of the company's stock, valued at approximately $3,188,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Exchange Traded Concepts LLC lifted its stake in shares of Qiagen by 2.3% in the first quarter. Exchange Traded Concepts LLC now owns 17,825 shares of the company's stock worth $716,000 after buying an additional 395 shares during the last quarter. SVB Wealth LLC acquired a new stake in shares of Qiagen in the first quarter worth $31,000. Walleye Trading LLC lifted its stake in shares of Qiagen by 14.6% in the first quarter. Walleye Trading LLC now owns 7,367 shares of the company's stock worth $296,000 after buying an additional 936 shares during the last quarter. Cetera Investment Advisers lifted its stake in shares of Qiagen by 14.4% in the fourth quarter. Cetera Investment Advisers now owns 11,297 shares of the company's stock worth $505,000 after buying an additional 1,418 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Qiagen by 93.9% in the first quarter. GAMMA Investing LLC now owns 2,943 shares of the company's stock worth $118,000 after buying an additional 1,425 shares during the last quarter. 70.00% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently weighed in on QGEN shares. Bank of America boosted their price objective on shares of Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Thursday, June 26th. Wall Street Zen lowered shares of Qiagen from a "strong-buy" rating to a "buy" rating in a research report on Monday, August 11th. Barclays assumed coverage on shares of Qiagen in a research report on Tuesday, June 24th. They set an "overweight" rating and a $55.00 target price on the stock. Cowen reaffirmed a "hold" rating on shares of Qiagen in a research report on Thursday, August 7th. Finally, UBS Group boosted their target price on shares of Qiagen from $48.00 to $50.00 and gave the stock a "neutral" rating in a research report on Thursday, August 7th. Three investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $49.69.

Qiagen Trading Up 1.2%

Shares of QGEN stock opened at $49.7140 on Friday. The firm has a market capitalization of $11.05 billion, a P/E ratio of 29.37, a price-to-earnings-growth ratio of 2.61 and a beta of 0.64. The company has a current ratio of 1.61, a quick ratio of 1.35 and a debt-to-equity ratio of 0.25. The firm's fifty day simple moving average is $48.61 and its 200 day simple moving average is $43.89. Qiagen N.V. has a 1 year low of $37.63 and a 1 year high of $51.88.

Qiagen (NYSE:QGEN - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.60 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.60. Qiagen had a net margin of 18.30% and a return on equity of 14.77%. The company had revenue of $533.54 million during the quarter, compared to analysts' expectations of $523.97 million. During the same quarter in the prior year, the company posted $0.55 EPS. The business's revenue was up 7.7% on a year-over-year basis. Qiagen has set its Q3 2025 guidance at 0.580- EPS. FY 2025 guidance at 2.350-2.350 EPS. As a group, sell-side analysts predict that Qiagen N.V. will post 2.26 EPS for the current year.

Qiagen Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were paid a $0.25 dividend. The ex-dividend date was Wednesday, July 2nd. This represents a dividend yield of 52.0%. Qiagen's dividend payout ratio is currently 14.79%.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.